Zobrazeno 1 - 10
of 50
pro vyhledávání: '"John A St. Cyr"'
Autor:
Linda M Shecterle, John A St. Cyr
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol 2009, Iss default, Pp 151-152 (2009)
Linda M Shecterle, John A St. CyrJacqmar, Inc., Minneapolis, MN, USAAbstract: Our aging skin undergoes changes with reductions in collagenous and elastic fibers, fibroblasts, mast cells, and macrophages with free radical production, which can result
Externí odkaz:
https://doaj.org/article/915ab791772a4d65bd39a6fe09c3e4d3
Publikováno v:
Cureus. 14(10)
Many of the complications of severe coronavirus disease-2019 (COVID-19) are caused by blood hyperviscosity driven by marked hyperfibrinogenemia. This results in a distinctive hyperviscosity syndrome which affects areas of high and low shear. A change
Publikováno v:
Cureus. 14(9)
Background The copy number of the oligonucleotide 5'-purine-uridine-uridine-purine-uridine-3' (purUUpurU) motif in a viral genome was previously shown to correlate with the severity of acute illness. This study aimed to determine whether purUUpurU co
Publikováno v:
SAGE Open Medicine, Vol 5 (2017)
Objectives: Breathing cold air can lead to bronchoconstriction and peripheral vasoconstriction, both of which could impact muscular performance by affecting metabolic demands during exercise. Successful solutions dealing with these physiological chan
Externí odkaz:
https://doaj.org/article/060a2c23b57641ff8ba13adadc8cd27d
Publikováno v:
Cureus. 14(6)
Background Coronavirus disease 2019 (COVID-19) can be associated with pathologic inflammation. The authors hypothesize that a high copy number of a purine-uridine-rich nucleotide motif is present in the genome of severe acute respiratory syndrome cor
Publikováno v:
Cureus
Cureus, 12
Cureus, 12, 2
Cureus, 12
Cureus, 12, 2
Item does not contain fulltext Blood viscosity is increased by elevated concentrations of acute phase reactants and hypergammaglobulinemia in inflammation. These increase blood viscosity by increasing plasma viscosity and fostering erythrocyte aggreg
Publikováno v:
Therapeutic Advances in Cardiovascular Disease. 10:185-191
Objective: Prosthetic heart valve implantation is commonly performed in patients that have valvular heart disease. Prior to clinical evaluation of newly developed prostheses, preclinical animal studies are performed for the assessment of both acute a
Publikováno v:
Cureus, 10, 5, pp. e2715
Cureus, 10, e2715
Cureus
Cureus, 10, e2715
Cureus
Contains fulltext : 196077.pdf (Publisher’s version ) (Open Access) Apolipoprotein(a) [apo(a)] is an apolipoprotein unique to lipoprotein(a) [Lp(a)]. Although it has no known function, Lp(a) is a risk factor for accelerated atherothrombosis. We hyp
Publikováno v:
Cureus
Cardiovascular disease still remains the leading cause of deaths worldwide. Atherosclerosis, the most common type of cardiovascular disease, has continued to progress due to many factors, genetics, and lifestyles. All cells require adequate adenosine
Publikováno v:
Cureus
Cureus, 10, e2377
Cureus, 10, 3, pp. e2377
Cureus, 10, e2377
Cureus, 10, 3, pp. e2377
Contains fulltext : 193215.pdf (Publisher’s version ) (Open Access) Deaths due to atherothrombosis are increasing throughout the world except in the lowest socio-demographic stratum. This is despite 60 years of study and expenditure of billions of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83039e502c854ed211b2595e51ae54c
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/193215
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/193215